AMP Capital Investors’s Orexigen Therapeutics, Inc. OREX Stock Holding History

AMP Capital Investors’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-27,257	Closed	-$572K	–	1308
2015 Q3	$572K	Sell	27,257 -6,537	-19%	-$224K	﹤0.01%	937
2015 Q2	$1.53M	Buy	33,794 +560	+2%	+$33.5K	0.01%	782
2015 Q1	$2.58M	Buy	33,234 +7,752	+30%	+$481K	0.02%	645
2014 Q4	$1.51M	Hold	25,482	–	–	0.01%	803
2014 Q3	$1.15M	Hold	25,482	–	–	0.01%	867
2014 Q2	$1.52M	Hold	25,482	–	–	0.01%	813
2014 Q1	$1.58M	Buy	25,482 +9,492	+59%	+$642K	0.01%	777
2013 Q4	$913K	Buy	15,990 +6,480	+68%	+$364K	0.01%	887
2013 Q3	$615K	Buy	+9,510	New	+$644K	﹤0.01%	937

Other funds holding OREX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AMP Capital Investors's OREX Position: Q4 2015 in Review

AMP Capital Investors sold out of Orexigen Therapeutics, Inc. (OREX) in Q4 2015, closing a stake of 27,257 shares — an estimated $572K sold.

AMP Capital Investors first reported a position in OREX in Q3 2013 and held it in 9 quarters. The position peaked at $2.58M in Q1 2015. 121 funds tracked by Wall St. Rank hold OREX as of Q4 2015.

AMP Capital Investors reported no remaining Orexigen Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
AMP Capital Investors sold 27,257 Orexigen Therapeutics, Inc. shares in Q4 2015, an estimated $572K.
AMP Capital Investors first reported a position in Orexigen Therapeutics, Inc. in Q3 2013 and held it in 9 quarters.
AMP Capital Investors's Orexigen Therapeutics, Inc. position peaked at $2.58M in Q1 2015.
121 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2015.

Based on AMP Capital Investors's 13F filing for Q4 2015, filed 16 Feb 2016.